Impact on HbA1c and body weight of switching from other GLP-1 receptor agonists to semaglutide: A model-based approach.
Saved in:
| Title: | Impact on HbA1c and body weight of switching from other GLP-1 receptor agonists to semaglutide: A model-based approach. |
|---|---|
| Authors: | Overgaard RV; Department of Quantitative Clinical Pharmacology, Novo Nordisk A/S, Søborg, Denmark., Lindberg SØ; Department of Medical and Science, Novo Nordisk A/S, Søborg, Denmark., Thielke D; Department of Global Medical Affairs, Novo Nordisk A/S, Søborg, Denmark. |
| Source: | Diabetes, obesity & metabolism [Diabetes Obes Metab] 2019 Jan; Vol. 21 (1), pp. 43-51. Date of Electronic Publication: 2018 Aug 23. |
| Publication Type: | Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 30047216 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Impact on HbA1c and body weight of switching from other GLP-1 receptor agonists to semaglutide: A model-based approach. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Overgaard+RV%22">Overgaard RV</searchLink>; Department of Quantitative Clinical Pharmacology, Novo Nordisk A/S, Søborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Lindberg+SØ%22">Lindberg SØ</searchLink>; Department of Medical and Science, Novo Nordisk A/S, Søborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Thielke+D%22">Thielke D</searchLink>; Department of Global Medical Affairs, Novo Nordisk A/S, Søborg, Denmark. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100883645%22">Diabetes, obesity & metabolism</searchLink> [Diabetes Obes Metab] 2019 Jan; Vol. 21 (1), pp. 43-51. <i>Date of Electronic Publication: </i>2018 Aug 23. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100883645 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1463-1326 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214628902%22">14628902 </searchLink><i>NLM ISO Abbreviation: </i>Diabetes Obes Metab |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30047216 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/dom.13479 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 43 Titles: – TitleFull: Impact on HbA1c and body weight of switching from other GLP-1 receptor agonists to semaglutide: A model-based approach. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Overgaard RV – PersonEntity: Name: NameFull: Lindberg SØ – PersonEntity: Name: NameFull: Thielke D IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2019 Jan Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 1463-1326 Numbering: – Type: volume Value: 21 – Type: issue Value: 1 Titles: – TitleFull: Diabetes, obesity & metabolism Type: main |
| ResultId | 1 |
